EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Ganglioglioma with anaplastic/high-grade transformation: Histopathologic, molecular, and epigenetic characterization of 3 cases

M Adelita Vizcaino iD, Caterina Giannini iD, Daniel Lalich, Ali Nael, Robert B Jenkins, Quynh Tran, Brent A Orr, Zied Abdullaev, Kenneth Aldape iD, Rachael A Vaubel iD

Journal of Neuropathology & Experimental Neurology · 2024

DOI: 10.1093/jnen/nlae038 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Neuropathology & Experimental Neurology, 2024. Verfasst von M Adelita Vizcaino und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Ganglioglioma, Brain Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Mayo Clinic Department of Laboratory Medicine and Pathology, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ganglioglioma (GG) with anaplasia (anaplastic ganglioglioma) is a rare and controversial diagnosis. When present, anaplasia involves the glial component of the tumor, either at presentation or at recurrence. To date, most published cases lack molecular characterization. We describe the histologic and molecular features of 3 patients presenting with BRAF p. V600E-mutant GG (CNS WHO grade 1) with high-grade glial transformation at recurrence. The tumors occurred in pediatric patients (age 9–16 years) with time to recurrence from 20 months to 7 years. At presentation, each tumor was low-grade, with a BRAFV600E-positive ganglion cell component and a glial component resembling pleomorphic xanthoastrocytoma (PXA) or fibrillary astrocytoma. At recurrence, tumors resembled anaplastic PXA or high-grade astrocytomas without neuronal differentiation. CDKN2A homozygous deletion (HD) was absent in all primary tumors. At recurrence, 2 cases acquired CDKN2A HD; the third case showed loss of p16 and MTAP immunoexpression, but no CDKN2A/B HD or mutation was identified. By DNA methylation profiling, all primary and recurrent tumors either grouped or definitely matched to different methylation classes. Our findings indicate that malignant progression of the glial component can occur in GG and suggest that CDKN2A/B inactivation plays a significant role in this process.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GangliogliomaBrain NeoplasmsHumansAdolescentChildMaleFemaleProto-Oncogene Proteins B-rafEpigenesis, GeneticNeoplasm Recurrence, LocalCell Transformation, Neoplastic

Stichwörter der Autor:innen

BRAF p. V600E-mutantCDKN2A/B inactivationAnaplasiaGangliogliomaMethylation class PXAWhole-genome DNA methylation profiling

Substanzen

Proto-Oncogene Proteins B-rafBRAF protein, human

Autor:innen und Institutionen

  • Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Minnesota, USA.
  • Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
  • Department of Pathology, Robert J. Dole VA Medical Center and Wesley Healthcare Center, Wichita, Kansas, USA.
  • Department of Pathology, Children's Hospital of Orange County and University of California Irvine, Orange County, California, USA.
  • Department of Pathology, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Laboratory of Pathology, National Cancer Institute/Center for Cancer Research, Bethesda, Maryland, USA.

ORCID-Profile: M Adelita Vizcaino, Caterina Giannini, Kenneth Aldape, Rachael A Vaubel

Förderung

  • Mayo Clinic Department of Laboratory Medicine and Pathology
  • NIH

Zitieren

APA

Vizcaino, M. A., Giannini, C., Lalich, D., Nael, A., Jenkins, R. B., Tran, Q., Orr, B. A., Abdullaev, Z., Aldape, K., & Vaubel, R. A. (2024). Ganglioglioma with anaplastic/high-grade transformation: Histopathologic, molecular, and epigenetic characterization of 3 cases. Journal of Neuropathology & Experimental Neurology. https://doi.org/10.1093/jnen/nlae038

Vancouver

Vizcaino MA, Giannini C, Lalich D, Nael A, Jenkins RB, Tran Q, et al. Ganglioglioma with anaplastic/high-grade transformation: Histopathologic, molecular, and epigenetic characterization of 3 cases. Journal of Neuropathology & Experimental Neurology. 2024. doi:10.1093/jnen/nlae038

BibTeX
@article{Vizcaino2024,
  author = {Vizcaino, M Adelita and Giannini, Caterina and Lalich, Daniel and Nael, Ali and Jenkins, Robert B and Tran, Quynh and Orr, Brent A and Abdullaev, Zied and Aldape, Kenneth and Vaubel, Rachael A},
  title = {Ganglioglioma with anaplastic/high-grade transformation: Histopathologic, molecular, and epigenetic characterization of 3 cases},
  journal = {Journal of Neuropathology & Experimental Neurology},
  year = {2024},
  doi = {10.1093/jnen/nlae038}
}
Kostenlos starten →